Although carbohydrate antigen 19-9 (CA19-9) and carcinoembryonic antigen (CEA) have been routinely used as biomarkers for the diagnosis/prognosis of CCA, the sensitivity and specificity of these markers could be improved [5,6,7]. The gene discussed is CEACAM5; the disease is cholangiocarcinoma.